Roman M. Shapiro

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Francisco Vera-Badillo, Roman M. Shapiro, Alberto Ocaña et al. · Annals of Oncology · 2013 · 113 citations · Full text

Nursing, Breast Oncology, Oncology +9

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock et al. · Blood Advances · 2021 · 41 citations · Full text

Ric Transplant, Hematological Malignancy, Transplantation +15

Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses

Shaobo Yang, Michal Sheffer, Isabel E. Kaplan et al. · Nature Biotechnology · 2024 · 40 citations · Full text

Inflammation, Microbial Pathogens, Non-pathogenic E. Coli +9

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution

Katie Maurer, Haesook T. Kim, Thomas M. Kuczmarski et al. · Blood Advances · 2021 · 37 citations · Full text

Chinese Pidgin Russian

Roman M. Shapiro · Journal of Pidgin and Creole Languages · 2010 · 33 citations

Translation Studies, Language Policy, Chatbot +25